Episode 4: Marianne Clancy, Executive Director at Cure HHT

Episode 4 June 23, 2021 00:38:12
Episode 4:  Marianne Clancy, Executive Director at Cure HHT
Few & Far Between: Conversations from the Front Lines of Drug Development
Episode 4: Marianne Clancy, Executive Director at Cure HHT

Jun 23 2021 | 00:38:12

/

Show Notes

On today’s podcast, host Wayne Bowden, Vice President of Partnerships and Strategy at Biorasi, talks with Marianne Clancy, Executive Director at Cure HHT, about the foundation and their goal of reducing the number of undiagnosed cases of HHT.

Other Episodes

Episode 15

December 01, 2021 00:40:52
Episode Cover

Episode 15: Dr. Terry Jo Bichell, Founder and Director of COMBINEDBrain

Raising awareness for rare diseases, such as Angelman Syndrome, should not be something parents, patients, and advocates have to do alone. Today's episode of...

Listen

Episode 45

December 12, 2024 00:37:26
Episode Cover

Episode 46: Dr. Carsten Rudolph, CEO and Managing Director at Ethris

"It's really a very important challenge we had from the very beginning, to see how to stabilize nanoparticles with the messenger RNA so they...

Listen

Episode 53

April 29, 2025 00:50:46
Episode Cover

Episode 53: Frank David, Founder and Managing Director, Pharmagellan

How do mission, vision, and data analysis fit into today's biotech goals? Host Chris O'Brien welcomes Frank David, Founder and Managing Director of Pharmagellan...

Listen